semaglutide
30% Cost Drop for Semaglutide vs Tirzepatide
Semaglutide remains expensive because manufacturers lock downstream pricing and bulk compounding is excluded from the 503B list, so patients cannot tap volume discounts. Between 7% and 35% of patients with liver disease progress each year, illustrating how small cost barriers can translate into large health impacts. Medical Disclaimer: This article